These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31820304)

  • 21. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Study on the Bioequivalence of Desloratadine in Healthy Chinese Subjects and the Association of Different Metabolic Phenotypes With UGT2B10 and CYP2C8 Genotypes.
    Niu S; Li Y; Dong W; Xia L; Shen T; Wang J; Wang Q; Zhang T; Zhang M; Liu G; Guo D; Fang Y
    Curr Drug Metab; 2020; 21(13):1031-1039. PubMed ID: 33109037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence study of two formulations of ibandronic acid 150-mg film-coated tablets in healthy volunteers under fasting conditions: a randomized, open-label, three-way, reference-replicated crossover study.
    Filipe A; Pedroso P; Almeida S; Neves R; Boudreault S
    Drugs R D; 2014 Jun; 14(2):105-12. PubMed ID: 24756462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence study of 2 orodispersible formulations of ondansetron 8 mg in healthy volunteers.
    Cánovas M; Rios J; Domenech G; Cebrecos J; Pelagio P; Canals M; Polonio F; Cabré F
    Arzneimittelforschung; 2012 Feb; 62(2):59-62. PubMed ID: 22344549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence of 2 Aripiprazole Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Xiang J; Xu N; Wang X; Li S; Yu Q; Liang M; Nan F; Shu S; Yan R; Zhu Y; Liao L
    Clin Pharmacol Drug Dev; 2021 Aug; 10(8):840-849. PubMed ID: 34105265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Safety, Bioavailability, and Pharmacokinetics of Oral Dexamethasone, 4-mg and 20-mg Tablets, in Healthy Volunteers Under Fasting and Fed Conditions: A Randomized Open-label, 3-way Crossover Study.
    Bashir Q; Acosta M
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):768-773. PubMed ID: 32900662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers.
    De Gregori S; Cipollina L; De Silvestri A; Ventura M; Michelini R; Morosini M; Montagna M; Tinelli C; Regazzi M; Molinaro M; Imberti R
    Ther Drug Monit; 2017 Apr; 39(2):118-123. PubMed ID: 28196046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
    Jáuregui I; Ramaekers JG; Yanai K; Farré M; Redondo E; Valiente R; Labeaga L
    Expert Opin Drug Saf; 2016 Jan; 15(1):89-98. PubMed ID: 26571227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence and pharmacokinetics of two 10-mg bisoprolol formulations as film-coated tablets in healthy white volunteers: a randomized, crossover, open-label, 2-period, single-dose, fasting study.
    Bus-Kwasnik K; Ksycinska H; Les A; Serafin-Byczak K; Rudzki PJ; Raszek J; Lazowski T; Bielak A; Wybraniec A
    Int J Clin Pharmacol Ther; 2012 Dec; 50(12):909-19. PubMed ID: 23006443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
    Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME
    Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.
    Tyl B; Kabbaj M; Azzam S; Sologuren A; Valiente R; Reinbolt E; Roupe K; Blanco N; Wheeler W
    J Clin Pharmacol; 2012 Jun; 52(6):893-903. PubMed ID: 21642470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
    Wolthers OD
    Biomed Res Int; 2013; 2013():626837. PubMed ID: 23956994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
    Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
    Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.